Clinical trial
MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence
NCT02778282 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 24, 2017
- Completion date
- August 31, 2021
- Enrollment
- 27 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
opioid use disorder